docetaxel anhydrous has been researched along with Neoplasms, Squamous Cell in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Deng, J; Liu, Q; Xia, Y; Zhang, J; Zhao, K | 1 |
| Dahlberg, SE; Hoang, T; Johnson, DH; Schiller, JH | 1 |
| Benzidane, B; Bonnetain, F; Borg, C; Bosset, JF; Cazorla, A; Delabrousse, E; Demarchi, M; Jary, M; Kaliski, A; Kim, S; Letondal, P; Mansi, L; Nguyen, T; Valmary-Degano, S | 1 |
| Cao, L; Cheng, HR; Li, RQ; Long, HL; Mao, WK; Xiao, BR; Zhai, XJ | 1 |
| Bae, SH; Baek, JH; Do, YR; Kim, JY; Kim, MK; Lee, KH; Park, KU; Ryoo, HM; Song, HS | 1 |
| Bruzzone, A; Dellepiane, M; Figliomeni, M; Ghio, R; Grillo-Ruggieri, F; Grimaldi, A; Mencoboni, M; Moratti, G; Rebella, L; Salami, A; Scasso, F; Spigno, F | 1 |
| Chilimoniuk, M; Maksimowicz, T; Olszewska, E | 1 |
| Dai, Y; Fan, CY; Neis, JP; Spring, PM; Vural, E; Xie, CH | 1 |
| Bi, CP; Chang, TH; Chen, MK; Lai, GM; Lin, JT; Liu, MT; Wang, JW | 1 |
| Glisson, BS | 1 |
| Awada, A; Castelijns, JA; De Mulder, P; Joosens, E; Kaanders, J; Kerger, J; Le Bouder, C; Nguyen, H; Schrijvers, D; Van den Weyngaert, D; Van Herpen, C; Van Laer, C; Vermorken, JB | 1 |
| Bourhis, J; Dalley, DN; Domenge, C; Dunant, A; Le Lann, L; Lewin, F; Mazumdar, M; Olivares, R; Paccagnella, A; Pignon, JP; Posner, M; Syz, N; Taylor, SG; Yver, A | 1 |
| Ayers, D; Chi, KN; Chia, S; Cripps, C; Fry, D; Gelmon, KA; Huan, S; Janke, S; McIntosh, L; Seymour, LK; Shabbits, JA; Stewart, D; Walsh, W | 1 |
| Akino, K; Hiratsuka, H; Imai, K; Kashima, L; Mita, H; Nishikawa, N; Noguchi, M; Ogi, K; Sasaki, Y; Satoh, A; Shinomura, Y; Suzuki, H; Tokino, T; Toyota, M | 1 |
| Kovács, AF | 1 |
| Busse, PM; Case, M; Costello, R; Goguen, L; Haddad, RI; Mahadevan, A; Norris, CM; Posner, MR; Sammartino, D; Stowell, S; Sullivan, C; Tishler, RB; Wirth, LJ | 1 |
| Ashcroft, L; Booton, R; Heighway, J; Morris, J; Thatcher, N; Ward, T | 1 |
2 review(s) available for docetaxel anhydrous and Neoplasms, Squamous Cell
| Article | Year |
|---|---|
The role of docetaxel in the management of squamous cell cancer of the head and neck.
Topics: Antineoplastic Agents, Phytogenic; Clinical Trials as Topic; Docetaxel; Head and Neck Neoplasms; Humans; Neoadjuvant Therapy; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Paclitaxel; Radiation-Sensitizing Agents; Taxoids | 2002 |
Adjusting for patient selection suggests the addition of docetaxel to 5-fluorouracil-cisplatin induction therapy may offer survival benefit in squamous cell cancer of the head and neck.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Neoplasms, Squamous Cell; Randomized Controlled Trials as Topic; Taxoids | 2004 |
8 trial(s) available for docetaxel anhydrous and Neoplasms, Squamous Cell
| Article | Year |
|---|---|
Does histology predict survival of advanced non-small cell lung cancer patients treated with platin-based chemotherapy? An analysis of the Eastern Cooperative Oncology Group Study E1594.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Docetaxel; Gemcitabine; Humans; Lung Neoplasms; Middle Aged; Neoplasms, Squamous Cell; Paclitaxel; Retrospective Studies; Taxoids; Treatment Outcome | 2013 |
Effects of docetaxel plus three-dimensional conformal radiation therapy on microvessel density and apoptosis expression in local advanced squamous non-small-cell lung cancer.
Topics: Aged; Apoptosis; Carcinoma, Non-Small-Cell Lung; Combined Modality Therapy; Docetaxel; Female; Humans; Male; Microvessels; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Prognosis; Quality of Life; Radiotherapy, Conformal; Survival Rate; Taxoids | 2015 |
A multi-center phase II study of docetaxel plus cisplatin as first-line therapy in patients with metastatic squamous cell esophageal cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free Survival; Docetaxel; Esophageal Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Squamous Cell; Neutropenia; Taxoids | 2010 |
Induction chemotherapy in head and neck cancer patients followed by concomitant docetaxel-based radiochemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Squamous Cell; Remission Induction; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2011 |
Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I-II feasibility study.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Docetaxel; Feasibility Studies; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Nausea; Neoplasm Staging; Neoplasms, Squamous Cell; Stomatitis; Survival Analysis; Survival Rate; Taxoids; Thrombocytopenia; Treatment Outcome | 2004 |
A phase I study of AMD473 and docetaxel given once every 3 weeks in patients with advanced refractory cancer: a National Cancer Institute of Canada-Clinical Trials Group trial, IND 131.
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Cohort Studies; Diarrhea; Docetaxel; Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasms; Neoplasms, Squamous Cell; Neutropenia; Organoplatinum Compounds; Prostatic Neoplasms; Taxoids; Treatment Outcome | 2004 |
Concurrent weekly docetaxel and concomitant boost radiation therapy in the treatment of locally advanced squamous cell cancer of the head and neck.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Docetaxel; Female; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasms, Squamous Cell; Radiotherapy Dosage; Remission Induction; Taxoids | 2006 |
ERCC1 mRNA expression is not associated with response and survival after platinum-based chemotherapy regimens in advanced non-small cell lung cancer.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Cisplatin; DNA Repair; DNA-Binding Proteins; Docetaxel; Endonucleases; Female; Humans; Ifosfamide; Lung Neoplasms; Male; Mitomycin; Neoplasm Staging; Neoplasms, Squamous Cell; Polymorphism, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Rate; Taxoids; Treatment Outcome | 2007 |
7 other study(ies) available for docetaxel anhydrous and Neoplasms, Squamous Cell
| Article | Year |
|---|---|
A study of concurrent chemoradiotherapy with weekly docetaxel and cisplatin for advanced esophageal squamous cell carcinoma with T4 and/or M1 lymph node metastasis or locoregional recurrence.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Docetaxel; Esophageal Neoplasms; Humans; Lymphatic Metastasis; Middle Aged; Neoplasms, Squamous Cell; Treatment Outcome; Young Adult | 2020 |
DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Cisplatin; Disease-Free Survival; Docetaxel; Female; Fluorouracil; Human papillomavirus 16; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Papillomavirus Infections; Prospective Studies; Retrospective Studies; Taxoids; Treatment Outcome | 2013 |
[Taxan induction chemotherapy and concomitant chemoradiotherapy with cisplatin in patients with locally advanced head and neck cancer--early results].
Topics: Anemia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Diarrhea; Docetaxel; Drug Administration Schedule; Fluorouracil; Head and Neck Neoplasms; Humans; Laryngeal Neoplasms; Male; Middle Aged; Neoplasms, Squamous Cell; Neutropenia; Oropharyngeal Neoplasms; Radiotherapy Dosage; Radiotherapy, Adjuvant; Squamous Cell Carcinoma of Head and Neck; Taxoids; Treatment Outcome; Vomiting | 2010 |
MicroRNA expression profiles of head and neck squamous cell carcinoma with docetaxel-induced multidrug resistance.
Topics: Antineoplastic Agents; Carcinoma; Carcinoma, Squamous Cell; Cell Line, Tumor; Docetaxel; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Humans; MicroRNAs; Neoplasms, Squamous Cell; Pharmacogenetics; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Taxoids | 2011 |
Chemotherapy with modified docetaxel, cisplatin, and 5-fluorouracil in patients with metastatic head and neck cancer.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease Progression; Docetaxel; Fluorouracil; Head and Neck Neoplasms; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasms, Squamous Cell; Palliative Care; Remission Induction; Retrospective Studies; Survival Rate; Taxoids | 2012 |
Small interfering RNA-induced CHFR silencing sensitizes oral squamous cell cancer cells to microtubule inhibitors.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Proteins; Cell Division; Docetaxel; Drug Resistance, Neoplasm; Female; G2 Phase; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Microtubules; Middle Aged; Mouth Neoplasms; Neoplasm Proteins; Neoplasms, Squamous Cell; Paclitaxel; Poly-ADP-Ribose Binding Proteins; RNA, Small Interfering; Taxoids; Ubiquitin-Protein Ligases | 2005 |
Maximized combined modality treatment of an unselected population of oral and oropharyngeal cancer patients. Final results of a pilot study compared with a treatment-dependent prognosis index.
Topics: Adult; Aged; Antineoplastic Agents; Cisplatin; Combined Modality Therapy; Docetaxel; Epidemiologic Methods; Female; Humans; Infusions, Intra-Arterial; Male; Middle Aged; Mouth Neoplasms; Neoplasms, Squamous Cell; Oropharyngeal Neoplasms; Prognosis; Recurrence; Survival Rate; Taxoids; Treatment Outcome; Treatment Refusal | 2006 |